Tryptophan protects hepatocytes against reactive oxygen species-dependent cell death via multiple pathways including...

Area of Science:

• Hepatology
• Immunology
• Biochemistry

Background:

• Hepatocyte apoptosis is crucial in immune-mediated hepatitis pathogenesis.
• Mechanisms of apoptosis signaling and effective hepatitis therapies require further investigation.

Purpose of the Study:

• To investigate the role of tryptophan (Trp) in suppressing interferon-gamma (IFN-γ)-mediated hepatic apoptosis.
• To elucidate the mechanisms by which Trp exerts its protective effects against liver injury.

Main Methods:

• In vitro studies using hepatocytes to assess Trp's effect on IFN-γ-induced apoptosis, caspase-3 activation, and reactive oxygen species (ROS) generation.
• Analysis of mitochondrial respiratory chain complexes (I, II, and III) and Nrf2-dependent gene expression.
• In vivo studies using an acetaminophen-induced hepatitis model to evaluate Trp's therapeutic potential.

Main Results:

• Trp inhibited downstream apoptotic events (cell death, caspase-3 activation) without affecting upstream signaling (STAT1, IRF1).
• Trp suppressed mitochondrial ROS generation induced by IFN-γ, partly by antagonizing IFN-γ's inhibition of complex I.
• Trp upregulated Nrf2-dependent antioxidant genes (NQO1, HO-1, GCS) in vitro and in vivo.
• Trp administration reduced liver injury in a ROS-dependent hepatitis model.

Conclusions:

• Trp protects hepatocytes from ROS-dependent injury through multiple mechanisms, including ROS suppression and Nrf2 pathway activation.
• Trp demonstrates therapeutic potential as an antioxidant drug for hepatitis.
• Trp acts as a regulator of Nrf2-dependent genes, offering a novel therapeutic avenue.